Lobe Sciences Ltd.
LOBEF
$0.0407
$0.004813.37%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 99.80K | 730.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 0.00 | 0.00 | 99.80K | 730.50K |
| Cost of Revenue | 11.20K | -160.40K | -160.40K | -159.10K | -152.30K |
| Gross Profit | -11.20K | 160.40K | 160.40K | 258.90K | 882.80K |
| SG&A Expenses | 1.73M | 1.46M | 1.43M | 1.31M | 1.70M |
| Depreciation & Amortization | 0.00 | 20.70K | 41.70K | 62.40K | 80.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.95M | 1.47M | 1.46M | 1.50M | 2.65M |
| Operating Income | -1.95M | -1.47M | -1.46M | -1.40M | -1.92M |
| Income Before Tax | -3.92M | -3.43M | -3.38M | -3.22M | -2.05M |
| Income Tax Expenses | 24.10K | 24.10K | 24.10K | 24.10K | 153.80K |
| Earnings from Continuing Operations | -3.95 | -3.45 | -3.41 | -3.24 | -2.20 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 107.00K | -- | -- | -- | -- |
| Net Income | -3.84M | -3.45M | -3.41M | -3.24M | -2.20M |
| EBIT | -1.95M | -1.47M | -1.46M | -1.40M | -1.92M |
| EBITDA | -1.91M | -1.42M | -1.40M | -1.33M | -1.84M |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.03 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.03 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 723.74M | 645.27M | 538.04M | 443.47M | 431.04M |
| Average Diluted Shares Outstanding | 723.74M | 645.27M | 538.04M | 443.47M | 431.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |